Brinker Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$590K Buy
22,799
+722
+3% +$18K 0.02% 672
2020
Q1
$537K Sell
22,077
-917
-4% -$23.1K 0.02% 619
2019
Q4
$642K Buy
22,994
+214
+0.9% +$5.54K 0.02% 648
2019
Q3
$547K Buy
22,780
+1,176
+5% +$31.3K 0.02% 674
2019
Q2
$616K Buy
+21,604
New +$540K 0.02% 628

Other funds holding VCYT

Brinker Capital's VCYT Position: Q2 2020 in Review

Brinker Capital increased its Veracyte (VCYT) stake by 3.3% in Q2 2020, buying an estimated $18K and bringing the position to 22,799 shares worth $590K. The position accounts for 0.02% of the portfolio, ranked #672.

Brinker Capital first reported a position in VCYT in Q2 2019 and has held it in 5 quarters since. The position peaked at $642K in Q4 2019. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

  • Brinker Capital held 22,799 shares of Veracyte worth $590K as of Q2 2020.
  • Brinker Capital bought 722 Veracyte shares in Q2 2020, an estimated $18K.
  • Veracyte made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #672 holding.
  • Brinker Capital first reported a position in Veracyte in Q2 2019 and has held it in 5 quarters since.
  • Brinker Capital's Veracyte position peaked at $642K in Q4 2019.
  • 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.